ST. LOUIS — Canopy BiosciencesTM, LLC, a leading provider of gene editing and personalized medicine technologies, announced today that it has launched two novel services for immuno-oncology and neurodegenerative disease. Both services allow researchers to assess the expression of nearly 800 disease-relevant genes in a single sample. The new Neuropathology service allows researchers to conduct […]
Canopy Biosciences launches CRISPR Complete Gene Editing Kits.
Canopy Biosciences signs deal with Array Bridge to market kits for impurity analysis.
ST. LOUIS, June 28, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it has launched a service for high throughput gene expression analysis. Based on the NanoString nCounter platform, the service works with a large array of sample types, including formats such as formalin-fixed […]
Canopy Biosciences signs agreement with Cosmo Bio to sell gene engineering products in Japan ST. LOUIS, June 22, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC (“Canopy Biosciences”), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. (“Cosmo Bio”) for its TUNR Flexible Gene Editing technology in […]
